Diabetes Melitus Sarcopenia
Conditions
Interventions
Participants will be provided with 1 kg of BCAA powder. After returning home, they are instructed to measure 10g per day with a scale and dissolve it in 350~450ml of water using a bottle.
Lifestyle
Sponsors
Fukui Michiaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients participating in this study must meet all of the following criteria 1.Participants in the previous study, Cohort Study of Patients with diabetes (Decision Notice No.: RBMR-E-466). 2.Patients who wish to take branched-chain amino acids (BCAA) as an oral dietary supplement to counteract sarcopenia/frailty associated with diabetes mellitus and who will start taking BCAA powder. 3.Patients in the first or second stage of diabetic nephropathy 4.Patients who are able to obtain written consent for participation in the study from themselves of their own free will. 5.Age: 20 years and older
Exclusion criteria
Exclusion criteria: Exclusion criteria 1.Women who are pregnant or may become pregnant 2.Patients with a history of anemia or undergoing treatment 3.Patients with congenital abnormality of branched-chain amino acid metabolism 4.Patients who are deemed inappropriate by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in body composition | — |
Secondary
| Measure | Time frame |
|---|---|
| Nutritional status (cholinesterase, fasting blood glucose, HbA1c, urinary albumin), inflammatory status (high sensitivity CRP), grip strength, physical findings (blood pressure) | — |
Contacts
Public ContactMasahide Hamaguchi
Kyoto Prefectural University of Medicine
Outcome results
None listed